US Patent 7235579 Phosphodiesterase 4 inhibitors
Patent 7235579 was granted and assigned to Memory Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Allen Hopper0
Ashok Tehim0
Erik Kuester0
Hans-Jurgen Ernst Hess0
Mike De Vivo0
Ruiping Liu0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+366 characters)
Article
Patent abstract
Selective PDE4 inhibition is achieved by 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds like rolipram and show selectivity with regard to inhibition of other classes of PDEs. The compounds of the present invention are of formula I:wherein R1, R2, and R3 are as defined herein.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07235579 Phosphodiesterase 4 inhibitors US Patent 7235579 Phosphodiesterase 4 inhibitors
Infobox
Patent Number
072355790
Patent Number
72355790
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072355790
Date of Patent
June 26, 2007
0Patent Application Number
102707240
Date Filed
October 16, 2002
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07235579 Phosphodiesterase 4 inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07235579
Date of patent
June 26, 2007
Patent application number
10270724
Date Filed
October 16, 2002
Patent primary examiner
Find more entities like US Patent 7235579 Phosphodiesterase 4 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.